Cite
LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma.
MLA
Zhao, Fen, et al. “LINC01004-SPI1 Axis-Activated SIGLEC9 in Tumor-Associated Macrophages Induces Radioresistance and the Formation of Immunosuppressive Tumor Microenvironment in Esophageal Squamous Cell Carcinoma.” Cancer Immunology, Immunotherapy, vol. 72, no. 6, June 2023, pp. 1835–51. EBSCOhost, https://doi.org/10.1007/s00262-022-03364-5.
APA
Zhao, F., Tian, H., Wang, Y., Zhang, J., Liu, F., & Fu, L. (2023). LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma. Cancer Immunology, Immunotherapy, 72(6), 1835–1851. https://doi.org/10.1007/s00262-022-03364-5
Chicago
Zhao, Fen, Hui Tian, Yungang Wang, Jianbo Zhang, Fang Liu, and Lei Fu. 2023. “LINC01004-SPI1 Axis-Activated SIGLEC9 in Tumor-Associated Macrophages Induces Radioresistance and the Formation of Immunosuppressive Tumor Microenvironment in Esophageal Squamous Cell Carcinoma.” Cancer Immunology, Immunotherapy 72 (6): 1835–51. doi:10.1007/s00262-022-03364-5.